PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical ...

Veeva Systems delivered strong Q2 results, with robust revenue growth and a fortress-like balance sheet, reinforcing its leadership in the biopharma sector. The company resolved its legal dispute with ...

For the three and six months ended July 31, 2025 and 2024, management used an estimated annual effective non-GAAP tax rate of 21.0%.

Veeva Systems, Inc. VEEV reported adjusted earnings per share (EPS) of $1.99 for the second quarter of fiscal 2026, which increased 22.8% from the year-ago figure of $1.62. Adjusted EPS beat the Zacks ...

The deal with Walgreens is likely to enhance sales of Veeva Data Cloud products including Veeva OpenData, Link, and Compass products. This partnership benefits Veeva Systems by expanding its reach ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...